All articles tagged with #otof gene
A new gene therapy using a modified virus has successfully restored hearing in teens and adults with OTOF-related congenital deafness, showing promising results especially in children aged 5-8, with significant safety and efficacy observed over a 12-month period.
A new gene therapy using a synthetic virus has successfully restored hearing in children, teenagers, and adults with a genetic form of deafness caused by OTOF mutations, showing significant improvements within six months and with no serious side effects, offering hope for broader treatments in the future.
A groundbreaking clinical trial demonstrates that gene therapy using a modified virus can successfully restore hearing in children and young adults with OTOF-related deafness, showing promising safety and efficacy, especially in children aged five to eight, marking a significant advancement in treating genetic hearing loss.
A new study has demonstrated the effectiveness of gene therapy in restoring hearing function for children with hereditary deafness caused by mutations of the OTOF gene. In a trial of six children, the gene therapy was found to be an effective treatment, resulting in dramatic improvements in speech perception and the ability to conduct normal conversation. This research represents the first human clinical trial to administer gene therapy for this condition, with promising results that could potentially benefit other forms of genetic hearing loss.